Apellis Pharmaceuticals (APLS) Receives Analyst Upgrade: A Closer Look
Hasnain Khan
October 9, 2023
Apellis Pharmaceuticals, a prominent name in the biopharmaceutical industry, has been making waves with its new eye disease treatment. On October 6, 2023, JP Morgan